Citoxlab, a CRO for non-clinical research, has announced an investment and partnership deal with Experimental Pharmacology and Oncology Berlin-Buch (EPO), a CRO providing services for preclinical oncology research
Seattle-based Aptevo Therapeutics, a clinical-stage biotechnology company, is using Genedata Biologics software to accelerate cancer research
A partnership between the University of Essex and Provide aims to improve the Uk's National Health Service (NHS) by implementing an AI-powered decision-making engine to determine the service a patient needs
FhP-AICOS (Fraunhofer AICOS) is using its knowledge in image processing and machine learning in healthcare to build a new solution to tackle cervical cancer, by making screening in low-resource areas easier and less costly
The Pistoia Alliance is now accepting entries for its 2018 President’s Startup Challenge for the next two months with the closing date on Monday, 3rd September 2018
Iris.ai has launched an exclusive pre-sale for its AIUR tokens
GenePlanet has announced it has closed a €10 million equity deal in exchange for a qualified minority stake with Zurich-based JF Investments
Prellis Biologics, a San Francisco-based 3D tissue printing company, announced that it has reached record speed and resolution in the quest to print human tissue with viable capillaries
Enamine, a chemical research organisation and TBD Biodiscovery, a GMP manufacturer of fine chemicals have announced a collaboration agreement to manage the transition of chemical synthesis of novel intermediates from laboratory to bulk scale under GMP standards
The Pistoia Alliance has released results of a survey that found that 72 per cent of science professionals believe their sector is lagging behind other industries in the development of AI
Robert Roe interviews MathWorks Loren Dean, on the use of AI in modelling and simulation
Every device needs to work seamlessly in its operating environment. But when that environment is a human body, things get complicated.
Christian Marcazzo, general manager at IDBS, highlights trends in life sciences research and development.
Data is a company’s biggest asset, yet for any organisation, keeping a handle on the potentially vast volumes and diversity of data that are generated can represent a considerable issue.
Rob Lalonde, Univa’s cloud VP general manager, considers the unique challenges posed by HPC
Deep learning has seen a huge rise in popularity over the last five years in both enterprise and scientific applications.
HPC users are increasingly turning to cloud technologies due to their flexibility and scalability, allowing them to quickly change the size of their workloads, adopt new technologies in a small testing environment and to help to increase the agility of a company working across multiple sites, or
